FDA Authorizes Emergency Use For Eli Lilly’s SARS-CoV-2 Antibody Treatment

Reuters (11/9, Beasley) reports the US Food and Drug Administration (FDA) authorized on Monday emergency use of Eli Lilly’s SARS-CoV-2 “antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions.” The FDA...